News and Trends 21 Nov 2018 Leo Pharma Enters Partnership to Develop Topical Treatment for Rare Skin Cancer The Danish company Leo Pharma and the US biotech PellePharm have joined forces to develop a topical treatment for rare forms of skin cancer. In the partnership, dermatology specialist Leo Pharma is paying PellePharm €61M. This is to fund a Phase III trial of PellePharm’s topical drug to treat the skin cancer Gorlin syndrome, which has no […] November 21, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 21 Nov 2018 5 Challenges to Unlocking the Real Potential of the Human Microbiome The study of the human microbiome — the microorganisms living in our body — is a very young field of research that is making big promises to treat all sorts of human diseases. As we get close to the approval of the first treatment based on microbiome science, it’s important to be aware of the […] November 21, 2018 - 9 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 20 Nov 2018 Phase I Gives Hope for First Zika Vaccine Results from a Phase I trial showed promising safety and efficacy of a potential first vaccine against the mosquito-borne Zika virus, developed by French biotech Valneva and US biopharma Emergent BioSolutions. In the US-based Phase I trial, 67 participants were injected with either placebo or inactivated forms of the virus as a vaccine. Two months later, […] November 20, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 20 Nov 2018 French Firm Gets Funding to Sell More Precise DNA Quantification System Paris-based Stilla Technologies has raised €16M in a Series A round to sell and develop a high-precision PCR system for DNA quantification with promising applications in diagnostics. The substantial round was led by Illumina Ventures, the investor arm of the gene sequencing giant Illumina. With the funds, Stilla Technologies plans to accelerate sales of its […] November 20, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 20 Nov 2018 Why Denmark Is a Strong Player in Europe’s Biotech Industry Denmark is a rapidly growing hotspot for biotech. During the BIO-Europe conference in Copenhagen, I talked to Mette Kirstine Agger, Managing Partner at the life sciences investor Lundbeckfonden Ventures, to learn more about how the industry is evolving in Europe and Denmark. The US has traditionally been the leader in biotech, but that seems to […] November 20, 2018 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 20 Nov 2018 Genentech and Immunocore Expand Partnership to Develop Cancer Immunotherapy Immunocore and the US biotech giant Genentech are building on their existing partnership to boost the clinical development of Immunocore’s immunotherapy for treating solid tumors. In the agreement, Genentech, a member of the Roche group, will pay UK-based Immunocore €87.3M ($100M) in an upfront payment and further undisclosed milestone payments as the immunotherapy progresses towards […] November 20, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 19 Nov 2018 Silk Biomaterial Could Regenerate the Brain After a Stroke A group of researchers in Spain has developed a silk biomaterial that can increase the survival of transplanted stem cells into the brain, improving recovery after a stroke or brain injury. The nervous system has limited capacity to recover after an injury, such as those produced by a stroke or brain trauma. Stem cell transplants […] November 19, 2018 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 19 Nov 2018 Anti-Inflammatory Treatments Get €40M Boost in Series B A Series B funding round has whipped up €40M for the Irish company Inflazome. This money will help to fund clinical trials for anti-inflammatory treatments targeting conditions such as Alzheimer’s and Parkinson’s disease. “We are extremely excited about this opportunity, which is such a large funding round in a European company,” Marco Boorsma, General Partner […] November 19, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 16 Nov 2018 AbbVie Enters Industry Collaboration to Fight Alzheimer’s and Parkinson’s Disease The UK biotech Mission Therapeutics has teamed up with AbbVie to develop new drugs to treat the neurodegenerative conditions Alzheimer’s disease and Parkinson’s disease. The new collaboration aims to fund the preclinical development of drugs that inhibit proteins called deubiquitinating enzymes. Deubiquitinating enzymes modify proteins in the cell, controlling essential functions such as what the […] November 16, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 16 Nov 2018 This Biotech Measures How Well Kidney Dialysis Machines Filter Your Blood We take a hop, skip and a jump into Tallinn, Estonia this week. Optofluid Technologies is developing sensors that measure blood toxin levels to see how well dialysis procedures are working in kidney failure patients. Mission: To improve the effectiveness of dialysis in kidney failure patients. Optofluid’s experimental optical sensor could give physicians detailed real-time […] November 16, 2018 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 15 Nov 2018 Soldier Bug Could Help Combat Antibiotic Resistance A garden insect makes a molecule that attacks the cell wall of bacteria, providing a new potential weapon in the fight against antibiotic resistance. Thanatin is a peptide molecule produced by the spined soldier bug Podisus maculiventris to control the types of bacteria that live in its gut. A research group from the University of Zurich […] November 15, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Inside Labiotech 15 Nov 2018 Biotech Money Insider – A Year of Investments in Europe Did you ever dream of having access to all the recent investments in the European Biotech space? Well, I did! That’s why we created Biotech Money Insider, the first book by Labiotech.eu. Since we launched our website, back in 2014, we gathered data on over 1000 active biotech companies in Europe. This year, we decided […] November 15, 2018 - 1 minutemin - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email